TY - JOUR
T1 - Capturing and monitoring global differences in untreated and treated end-stage kidney disease, kidney replacement therapy modality, and outcomes
AU - Pecoits-Filho, Roberto
AU - Okpechi, Ikechi G.
AU - Donner, Jo-Ann
AU - Harris, David C. H.
AU - Aljubori, Harith M.
AU - Bello, Aminu K.
AU - Bellorin-Font, Ezequiel
AU - Caskey, Fergus J.
AU - Collins, Allan
AU - Cueto-Manzano, Alfonso M.
AU - Feehally, John
AU - Goh, Bak Leong
AU - Jager, Kitty J.
AU - Nangaku, Masaomi
AU - Rahman, Muhibur
AU - Sahay, Manisha
AU - Saleh, Abdulkarim
AU - Sola, Laura
AU - Turan Kazancioglu, Rumeyza
AU - Walker, Rachael C.
AU - Walker, Robert
AU - Yao, Qiang
AU - Yu, Xueqing
AU - Zhao, Ming-Hui
AU - Johnson, David W.
PY - 2020/3
Y1 - 2020/3
N2 - A large gap between the number of people with end-stage kidney disease (ESKD) who received kidney replacement therapy (KRT) and those who needed it has been recently identified, and it is estimated that approximately one-half to three-quarters of all people with ESKD in the world may have died prematurely because they could not receive KRT. This estimate is aligned with a previous report that estimated that >3 million people in the world died each year because they could not access KRT. This review discusses the reasons for the differences in treated and untreated ESKD and KRT modalities and outcomes and presents strategies to close the global KRT gap by establishing robust health information systems to guide resource allocation to areas of need, inform KRT service planning, enable policy development, and monitor KRT health outcomes.
AB - A large gap between the number of people with end-stage kidney disease (ESKD) who received kidney replacement therapy (KRT) and those who needed it has been recently identified, and it is estimated that approximately one-half to three-quarters of all people with ESKD in the world may have died prematurely because they could not receive KRT. This estimate is aligned with a previous report that estimated that >3 million people in the world died each year because they could not access KRT. This review discusses the reasons for the differences in treated and untreated ESKD and KRT modalities and outcomes and presents strategies to close the global KRT gap by establishing robust health information systems to guide resource allocation to areas of need, inform KRT service planning, enable policy development, and monitor KRT health outcomes.
KW - end-stage kidney disease
KW - global health
KW - health information systems
KW - health services accessibility
KW - kidney replacement therapy
KW - registries
UR - http://www.scopus.com/inward/record.url?scp=85079209524&partnerID=8YFLogxK
U2 - https://doi.org/10.1016/j.kisu.2019.11.001
DO - https://doi.org/10.1016/j.kisu.2019.11.001
M3 - Review article
C2 - 32149004
SN - 2157-1724
VL - 10
SP - e3-e9
JO - Kidney international. Supplement
JF - Kidney international. Supplement
IS - 1
ER -